Related Experiment Video
Updated: May 12, 2026

Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional (3D) Model
Published on: June 11, 2014
Integrin-binding protein nischarin interacts with tumor suppressor liver kinase B1 (LKB1) to regulate cell migration
Prachi Jain1, Somesh Baranwal, Shengli Dong
1Department of Biochemistry and Molecular Biology, School of Medicine, Louisiana State University Health Science Center, New Orleans, Louisiana 70112, USA.
Abstract:
Biallelic inactivation of LKB1, a serine/threonine kinase, has been detected in 30% of lung adenocarcinomas, and inhibition of breast tumor growth has been demonstrated. We have identified the tumor suppressor, Nischarin, as a novel binding partner of LKB1. Our mapping analysis shows that the N terminus of Nischarin interacts with amino acids 44-436 of LKB1. Time lapse microscopy and Transwell migration data show that the absence of both Nischarin and LKB1 from an invasive breast cancer cell line (MDA-MB-231) enhances migration as measured by increased distance and speed of migrating cells. Our data suggest that this is a result of elevated PAK1 and LIMK1 phosphorylation. Moreover, the absence of Nischarin and LKB1 increased tumor growth in vivo. Consistent with this, the percentage of S phase cells was increased, as demonstrated by flow cytometry and enhanced cyclin D1. The absence of Nischarin and LKB1 also led to a dramatic increase in the formation of lung metastases. Our studies, for the first time, demonstrate functional interaction between LKB1 and Nischarin to inhibit cell migration and breast tumor progression. Mechanistically, we show that these two proteins together regulate PAK-LIMK-Cofilin and cyclin D1/CDK4 pathways.
Insights
The tumor suppressor Nischarin interacts with LKB1 to inhibit breast cancer progression. Loss of both proteins enhances cell migration, tumor growth, and lung metastasis formation.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Biallelic inactivation of LKB1 (serine/threonine kinase) occurs in 30% of lung adenocarcinomas.
- LKB1 is known to inhibit breast tumor growth.
- Nischarin is a tumor suppressor with an uncharacterized role in cancer progression.
Purpose of the Study:
- To identify novel binding partners of LKB1.
- To investigate the functional interaction between Nischarin and LKB1 in breast cancer.
- To elucidate the molecular mechanisms by which Nischarin and LKB1 regulate cell migration and tumor progression.
Main Methods:
- Protein interaction mapping using N-terminal mapping.
- Cell migration assays (time-lapse microscopy, Transwell migration).
- In vivo tumor growth and metastasis studies.
- Flow cytometry for cell cycle analysis.
- Western blotting for protein phosphorylation and expression analysis.
Main Results:
- Nischarin directly binds to LKB1 (amino acids 44-436).
- Absence of Nischarin and LKB1 significantly enhances MDA-MB-231 cell migration and invasion.
- Loss of Nischarin and LKB1 increases tumor growth, S-phase population, and cyclin D1 levels in vivo.
- Co-absence of Nischarin and LKB1 dramatically increases lung metastasis formation.
- The combined absence of Nischarin and LKB1 elevates PAK1 and LIMK1 phosphorylation, suggesting dysregulation of the PAK-LIMK-Cofilin pathway.
- These proteins together regulate cyclin D1/CDK4 pathways.
Conclusions:
- This study demonstrates a novel functional interaction between the tumor suppressor Nischarin and LKB1.
- Nischarin and LKB1 cooperate to inhibit breast cancer cell migration, invasion, tumor growth, and metastasis.
- The mechanism involves the regulation of PAK-LIMK-Cofilin and cyclin D1/CDK4 pathways.
Related Concept Videos
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Intracellular Signaling Affects Focal Adhesions
Some...
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Selectins
Adherens Junctions
Adherens Junctions are Dynamic
The endothelial cells...

